Opportunity Information: Apply for RFA DA 13 007
Apply for RFA DA 13 007
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on May 11, 2012 and posted on May 11, 2012.
- Applicants must submit their applications by Aug 22, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) County governments For profit organizations other than small businesses Native American tribal governments (Federally recognized) City or township governments Private institutions of higher education Independent school districts State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01)" (Funding Opportunity Number RFA-DA-13-007), was issued by the National Institute on Drug Abuse (NIDA) within the National Institutes of Health. It supports R01 research projects that directly test the idea that when people reduce their illicit drug use, measurable health outcomes improve in meaningful ways. The core purpose is to move beyond drug-use measures alone and to build a stronger evidence base that links reductions in use to concrete clinical or biological benefits in patients, which in turn can strengthen how substance use disorder (SUD) treatments are evaluated.
The research scope is deliberately broad and includes both prospective and retrospective study designs. Applicants are encouraged to identify, characterize, and quantify beneficial health outcomes that track with reduced use of a specific illicit drug, or with reductions in illicit drug use more generally. The opportunity also emphasizes the development, refinement, or validation of strategies, methods, and tools that can detect and monitor these positive health changes. That can include clinical assessments, functional measures, and laboratory approaches such as biomarkers, as long as they are tied to demonstrating salutary consequences of reduced drug exposure. In other words, projects can focus on discovering what health improvements occur when use decreases, or on proving that a particular measurement approach reliably captures those improvements.
A major translational motivation sits behind the announcement. NIDA highlights that establishing credible, validated health outcome measures associated with changing drug use could provide additional endpoints for drug abuse research and help the field assess new therapeutic agents for SUDs. The long-term regulatory objective is especially explicit: to generate evidence that could help regulatory authorities accept reductions in illicit drug use as a valid, meaningful outcome measure in pharmacotherapy clinical trials for SUD treatment. This reflects a practical challenge in addiction research and product development: demonstrating that changes in use are not only statistically significant, but also clinically significant in ways that matter for patient health and public health.
In terms of administrative details, this is a discretionary grant program with no cost sharing or matching requirement. The estimated total funding was $3,000,000, with an award ceiling of $500,000. The opportunity was posted and created on May 11, 2012, with an original and current closing date of August 22, 2012, and an archive date of September 22, 2012. The CFDA number listed is 93.279 (Drug Abuse and Addiction Research Programs), placing it squarely within NIH biomedical and behavioral research support.
Eligibility is expansive and includes a wide range of domestic and international applicants. Eligible applicants include federal, state, county, city or township governments; special district governments; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits with and without 501(c)(3) status (excluding higher education when specified); public housing authorities/Indian housing authorities; independent school districts; small businesses; and for-profit organizations other than small businesses. The eligibility language also explicitly includes faith-based and community-based organizations, regional organizations, U.S. territories or possessions, and multiple categories of minority-serving institutions (such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, and tribally controlled colleges and universities). Federally recognized tribal governments and other tribal organizations are eligible as well. Notably, non-U.S. entities (foreign institutions) are eligible to apply, and foreign components of U.S. organizations are allowed as defined under NIH policy.
Finally, the announcement provides an additional information link hosted on the NIH grants website (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-007.html). For access or linking issues, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled "Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01)."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA-DA-13-007.
Which agency and institute issued this announcement?
This announcement was issued by the National Institute on Drug Abuse (NIDA) within the National Institutes of Health (NIH).
What type of grant mechanism is supported?
This opportunity supports R01 research projects.
What is the central purpose of the research supported by this opportunity?
The core purpose is to directly test the idea that when people reduce their illicit drug use, measurable health outcomes improve in meaningful ways. The goal is to strengthen the evidence linking reductions in use to concrete clinical or biological benefits, and to support stronger evaluation of substance use disorder (SUD) treatments.
How is this opportunity different from studies that focus only on drug-use measures?
It is designed to move beyond drug-use measures alone by building an evidence base that connects reduced illicit drug use to clinically or biologically meaningful improvements in health outcomes.
What kinds of study designs are allowed?
The research scope is broad and includes both prospective and retrospective study designs.
What research topics or aims are encouraged?
Applicants are encouraged to identify, characterize, and quantify beneficial health outcomes that track with reduced use of a specific illicit drug or with reductions in illicit drug use more generally.
Does the opportunity support work on measurement methods and tools?
Yes. It emphasizes development, refinement, or validation of strategies, methods, and tools that can detect and monitor positive health changes associated with reduced illicit drug exposure.
What kinds of health outcome measures are in scope?
Examples noted include clinical assessments, functional measures, and laboratory approaches such as biomarkers, as long as they are tied to demonstrating salutary (beneficial) consequences of reduced drug exposure.
Can a project focus on discovering health improvements rather than developing a new tool?
Yes. Projects can focus either on discovering what health improvements occur when illicit drug use decreases, or on demonstrating that a particular measurement approach reliably captures those improvements.
What is the translational motivation behind this announcement?
NIDA highlights that establishing credible, validated health outcome measures associated with changing drug use can provide additional endpoints for drug abuse research and help the field assess new therapeutic agents for SUDs.
Is there a stated long-term regulatory objective?
Yes. A long-term objective is to generate evidence that could help regulatory authorities accept reductions in illicit drug use as a valid, meaningful outcome measure in pharmacotherapy clinical trials for SUD treatment.
What is the total estimated funding amount for this opportunity?
The estimated total funding amount is $3,000,000.
What is the award ceiling?
The award ceiling is $500,000.
Is cost sharing or matching required?
No. This is a discretionary grant program with no cost sharing or matching requirement.
When was this opportunity posted/created?
It was posted and created on May 11, 2012.
What was the application closing date?
The original and current closing date listed is August 22, 2012.
When was the opportunity archived?
The archive date is September 22, 2012.
What is the CFDA number associated with this funding opportunity?
The CFDA number is 93.279 (Drug Abuse and Addiction Research Programs).
Who is eligible to apply?
Eligibility is expansive and includes a wide range of domestic and international applicants. Eligible applicants include:
- Federal, state, county, city, or township governments
- Special district governments
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Nonprofits with 501(c)(3) status (excluding higher education when specified)
- Nonprofits without 501(c)(3) status (excluding higher education when specified)
- Public housing authorities/Indian housing authorities
- Independent school districts
- Small businesses
- For-profit organizations other than small businesses
- Faith-based and community-based organizations
- Regional organizations
- U.S. territories or possessions
- Federally recognized tribal governments and other tribal organizations
- Minority-serving institutions (including HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, and tribally controlled colleges and universities)
Are non-U.S. (foreign) organizations eligible to apply?
Yes. Non-U.S. entities (foreign institutions) are eligible to apply.
Are foreign components of U.S. organizations allowed?
Yes. Foreign components of U.S. organizations are allowed as defined under NIH policy.
Where can applicants find the official funding announcement?
The announcement includes an NIH grants website link: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-007.html
Who should be contacted if there are access or linking issues with the announcement page?
The contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: Population Based Surveillance for Hemoglobinopathies
Previous opportunity: New York Conservation Innovation Grants
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 13 007
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 13 007) also looked into and applied for these:
| Funding Opportunity |
|---|
| Synthesis and Preclinical Evaluation of Medications to Treat Substance Use Disorders (SUDs) (R01) Apply for RFA DA 13 004 Funding Number: RFA DA 13 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44) Apply for PA 12 196 Funding Number: PA 12 196 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Community Clinical Oncology Program Groups (U10) Apply for RFA CA 12 007 Funding Number: RFA CA 12 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Minority Based Community Clinical Oncology Program Groups (U10) Apply for RFA CA 12 008 Funding Number: RFA CA 12 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIMH Career Transition Award for Tenure Track and Tenured Intramural Investigators (K22) Apply for PAR 12 201 Funding Number: PAR 12 201 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Education Grants for Statistical and Computational Training in the Genetics of Addiction (R25) Apply for PAR 12 199 Funding Number: PAR 12 199 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| U.S. India Bilateral Collaborative Research Partnerships (CRP) on the Prevention of HIV/AIDS and Co morbidities (R21) Apply for RFA AI 12 033 Funding Number: RFA AI 12 033 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Establish Sharing of Human Brain Image Data Relevant to Drug Addiction (Admin Supp) Apply for PAR 12 204 Funding Number: PAR 12 204 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Advancing Exceptional Research on HIV/AIDS (R01) Apply for RFA DA 13 008 Funding Number: RFA DA 13 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Identifying Non coding RNA Targets for Early Detection of Cancer (R01) Apply for PA 12 213 Funding Number: PA 12 213 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Identifying Non coding RNA Targets for Early Detection of Cancer (R21) Apply for PA 12 214 Funding Number: PA 12 214 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Biomarkers for Early Detection of Hematopoietic Malignancies (R21) Apply for PA 12 220 Funding Number: PA 12 220 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Biomarkers for Early Detection of Hematopoietic Malignancies (R01) Apply for PA 12 221 Funding Number: PA 12 221 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cohort Studies of HIV/AIDS and Substance Use (U01) Apply for PAR 12 222 Funding Number: PAR 12 222 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Advancing Community level Approaches to Reduce HIV Infection in Highly Impacted Communities (R01) Apply for RFA MH 13 090 Funding Number: RFA MH 13 090 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Advancing Community level Approaches to Reduce HIV Infection in Highly Impacted Communities (R21) Apply for RFA MH 13 091 Funding Number: RFA MH 13 091 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Community level Approaches to Reduce HIV Infection in Highly Impacted Communities (R34) Apply for RFA MH 13 092 Funding Number: RFA MH 13 092 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Addressing Needs of Informal Caregivers of Individuals with Alzheimers Disease in the Context of Sociodemographic Factors (R01) Apply for RFA NR 13 001 Funding Number: RFA NR 13 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Physical activity and weight control interventions among cancer survivors Effects on biomarkers of prognosis and survival (R01) Apply for PAR 12 228 Funding Number: PAR 12 228 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Physical activity and weight control interventions among cancer survivors Effects on biomarkers of prognosis and survival (R21) Apply for PAR 12 229 Funding Number: PAR 12 229 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 13 007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.